Johnson & Johnson MedTech announced new advances in surgical robotic technology with physical AI capabilities.
The company's advances create simulated environments to accelerate future product innovation, optimize clinical workflows, and improve training for clinical teams.
J&J MedTech applied the AI-driven simulation in the development of its Monarch surgical robotic platform for urology.
The company plans to launch the platform in the U.S. in 2026.
The medtech giant says its advances create simulated environments to accelerate future product innovation, optimize clinical workflows and improve training for clinical teams.
Author's summary: J&J MedTech advances surgical robotics with AI technology.